Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
An embryonal tumor with multilayered rosettes, C19MC-altered, occurring in adults.
Biomarker and diagnostic research for adult embryonal tumor with multilayered rosettes, c19mc-altered has been reported in the published literature.
6 clinical trials registered, 6 recruiting. Interventions under study include drug therapy, procedural interventions, biologic therapy, and other interventions. Pipeline includes 1 PHASE2, 3 PHASE1, 1 EARLY_PHASE1. Research is primarily sponsored by academic and government institutions.
NCT ID | Title | Phase | Sponsor | Status |
|---|---|---|---|---|
[NCT04794686](https://clinicaltrials.gov/study/NCT04794686) |
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 3:00 PM UTC
Common questions about adult embryonal tumor with multilayered rosettes, c19mc-altered
ETMR One: An International Registry and Research Platform for Children With Embryonal Tumor With Multilayer Rosettes |
— |
Hackensack Meridian Health |
RECRUITING |
[NCT06942039](https://clinicaltrials.gov/study/NCT06942039) | Pilot Study of IT Topotecan and Maintenance Chemotherapy for HR-EBTs in Children < 6 Years, Post Consolidation | EARLY_PHASE1 | C17 Council | RECRUITING |
[NCT07390539](https://clinicaltrials.gov/study/NCT07390539) | B7-H3.CD28Z.CART in CNS Neoplasms | PHASE1 | Robbie Majzner | RECRUITING |
[NCT06193759](https://clinicaltrials.gov/study/NCT06193759) | Immunotherapy for Malignant Pediatric Brain Tumors Employing Adoptive Cellular Therapy (IMPACT) | PHASE1 | Children's National Research Institute | RECRUITING |
[NCT06861244](https://clinicaltrials.gov/study/NCT06861244) | Embryonal Tumor With Multilayered Rosettes | PHASE2 | University of California, San Francisco | RECRUITING |
202 publications have been identified in PubMed for adult embryonal tumor with multilayered rosettes, c19mc-altered. Research spans Basic Science / Preclinical (29%), Epidemiology / Natural History (20%), and Clinical Trial Publication (14%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 58 | 29% |
Disease patterns and progression | 40 | 20% |
Clinical study results | 28 | 14% |
Patient case studies | 27 | 13% |
Research summaries | 21 | 10% |
Testing and diagnosis research | 19 | 9% |
New treatment approaches | 9 | 4% |
Kojima M (2026). [PMID: 41457639](https://pubmed.ncbi.nlm.nih.gov/41457639/). *Cancer Sci*. [Basic Science / Preclinical]
Nishida A (2026). [PMID: 42203325](https://pubmed.ncbi.nlm.nih.gov/42203325/). *Anticancer Res*. [Diagnostic / Biomarker]
Power EA (2026). [PMID: 41670812](https://pubmed.ncbi.nlm.nih.gov/41670812/). *Childs Nerv Syst*. [Basic Science / Preclinical]
Chen X (2026). [PMID: 41849381](https://pubmed.ncbi.nlm.nih.gov/41849381/). *Proc Natl Acad Sci U S A*. [Basic Science / Preclinical]
Dalton KL (2026). [PMID: 41707643](https://pubmed.ncbi.nlm.nih.gov/41707643/). *J Pediatr Hematol Oncol Nurs*. [Epidemiology / Natural History]
Karna NK (2026). [PMID: 41913258](https://pubmed.ncbi.nlm.nih.gov/41913258/). *J Med Case Rep*. [Review / Meta-Analysis]
Demir E (2026). [PMID: 40983773](https://pubmed.ncbi.nlm.nih.gov/40983773/). *Strahlenther Onkol*. [Epidemiology / Natural History]
Sarvode S (2026). [PMID: 41712211](https://pubmed.ncbi.nlm.nih.gov/41712211/). *JAMA Netw Open*. [Epidemiology / Natural History]
Morgenstern DA (2026). [PMID: 41823176](https://pubmed.ncbi.nlm.nih.gov/41823176/). *Pediatr Blood Cancer*. [Clinical Trial Publication]
Metts J (2026). [PMID: 41088849](https://pubmed.ncbi.nlm.nih.gov/41088849/). *Pediatr Blood Cancer*. [Clinical Trial Publication]